Navigation Links
Health Diagnostic Laboratory, Inc. (HDL, Inc.) Partners With Gamma Therapeutics to Offer Breakthrough Diagnostic Assay for Heart Attack and Stroke Risk
Date:3/1/2011

RICHMOND, Va., March 1, 2011 /PRNewswire/ -- Health Diagnostic Laboratory Inc. (HDL, Inc.), www.myhdl.com, announced today its partnership to develop a novel laboratory developed test with Gamma Therapeutics, Inc., an Oregon-based biotechnology venture developing diagnostic test and surgical therapy solutions for the cardiovascular disease industry.

Cardiovascular disease (CVD), coronary heart disease (CHD) and stroke are responsible for 16.7 million, or 29.9% of total global deaths associated with some type of disease, according to the World Health Organization. In 2010, CVD became the leading cause of death in developing countries. At least 20 million people survive heart attacks and strokes every year; many require continuing costly clinical care.

Gamma Therapeutics, launched in November 2010, is bringing to market, in a joint product development effort with HDL, Inc., a novel CVD Risk Assay to enhance cardiologists' ability to assess heart attack and stroke risk by providing a new predictive and prognostic tool. The laboratory developed CVD Risk Assay is based upon a naturally occurring clotting protein in human blood called Gamma Prime Fibrinogen, a biomarker strongly associated with cardiovascular disease. The laboratory-developed test version of the Gamma Therapeutics' CVD Assay will be offered exclusively by HDL, Inc., which also will take the lead in BETA testing of the assay for FDA approval.

The Gamma Therapeutics' executive management team includes David H. Farrell, Ph.D., Founder and CSO and David F. Eastman, M.Sc., CEO. Its science advisory board is comprised of leading scientists in cardiovascular disease, pathology and hematology research, with expertise in CVD patient medicine and preventative care, cardiovascular surgery, heart attack and stroke risk assessment, clinical and diagnostic testing, surgery-based treatment and business experience in growing biotechnology and medical device ven
'/>"/>

SOURCE Health Diagnostic Laboratory, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
3. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. Tone Deafness Explained, from the Harvard Health Letter
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
8. ViroPharma to Present at Three Upcoming Healthcare Conferences
9. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
10. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
11. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... As health officials across the Midwest warn against the widespread ... Michigan will offer free diagnostic testing for ... to administer tests and, in some cases, fill the matching ... the study. The Grand Rapids, Mich. ...
(Date:1/15/2014)... , Jan. 15, 2014 Massachusetts General ... AMGN ) announced today that they ... and validate new therapeutic targets and develop novel ... disorder that affects millions worldwide. The MGH-Broad-Amgen collaboration ...
(Date:1/15/2014)... , Jan. 15, 2014  Manufacturers, suppliers and ... be able to protect their most important business ... http://photos.prnewswire.com/prnh/20130716/CL46586LOGO ) Because of the ... steadfastly remains one of the most litigious industry ...
Breaking Medicine Technology:Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Intellectual Property Insurance for Medical-related Products and Services 2
... (Nasdaq: ERES ) announced today that it will ... May 2, after the market closes. After the release, the ... that day. For the conference call, interested ... or 1-412-858-4600 when calling internationally. There will be a playback ...
... April 15, 2011 Atrium Medical Corporation has provided ... Atrium University, at www.AtriumU.com .  "Atrium has been ... for our customers," said Jeff McGill, Senior Vice President ... guidelines for companies, interactions with nurses and physicians, we ...
Cached Medicine Technology:ERT Reports First Quarter 2011 Operating Results on May 2, 2011 2Atrium Provides Grant to Establish Education Web Site at AtriumU.com 2
(Date:4/17/2014)... non-cancerous prostate tissue may have nearly twice the risk ... inflammation, according to results of a new study led ... , The link between persistent inflammation and cancer was ... those with a Gleason score between 7 and ... and rapidly growing prostate cancers. , "What we,ve shown ...
(Date:4/17/2014)... most popular vaccine brands for children may not be ... some cost factors when choosing vaccines, driving the market ... to a new study by University of Illinois researchers. ... driven by numerous factors," says Sheldon H. Jacobson, a ... science and of mathematics at the U. of I. ...
(Date:4/17/2014)... of California, San Diego School of Medicine report that ... a recent major loss are more likely to be ... study is published in this month,s issue of the ... compassionate behaviors are associated with better health and well-being ... ways to improve the outcomes of individuals whose deficits ...
(Date:4/17/2014)... Hospital Pediatrician-in-Chief Jon McCullers, MD, was recently invited ... of Nature Reviews Microbiology , one of ... a world-renowned infectious disease specialist, and chair of ... Tennessee Health Science Center, analyzed the epidemiology and ... 1968 pandemics, as well as more recent 2009 ...
(Date:4/17/2014)... 2014) Doctors who treat patients with a ... can face an agonizing treatment decision. , The ... and help relieve shortness of breath. But some ... can cause potentially fatal complications following transplantation. , ... Dilling, medical director of Loyola University Medical Center,s ...
Breaking Medicine News(10 mins):Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Study recalculates costs of combination vaccines 2Health News:The ilk of human kindness 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3
... - Avoid Select Vitamins, Try Acupuncture, NORTHBROOK, ... American College of Chest Physicians (ACCP) recommend,against the ... general,screening of lung cancer. Published as a supplement ... of the ACCP, the guidelines cite there,is little ...
... Ohio, Sept. 10 AtriCure, Inc.,(Nasdaq: ATRC ... and selling innovative cardiac surgical devices, announced,today that ... implanted during an open-heart surgical procedure performed by,Professor ... University of Zurich,in Switzerland with the support of ...
... think they have a vaginal yeast infection are wrong ... treating their problem, says a Saint Louis University researcher ... isnt a yeast infection, said Susan Hoffstetter, Ph.D., assistant ... Louis University School of Medicine and a SLUCare womens ...
... Sept. 10 Sangamo,BioSciences, Inc. (Nasdaq: SGMO ) ... officer, will provide an update on,the progress of Sangamo,s ... business strategy at 1:30 pm (PT) on Monday,September 17, ... San Francisco. The presentation will be webcast live ...
... A vascular surgery technique pioneered at UT Southwestern ... thigh to repair the aorta does not create blood-flow ... patients, researchers report. , Vascular disease is a major ... of the aorta. Inserting synthetic grafts to repair damaged ...
... could fight cancer, heart disease, researchers say , , MONDAY, Sept. ... life, a new European study suggests. , "The intake ... from any cause of death," said lead researcher Dr. Philippe ... Lyon, France. , The new finding, published in the Sept. ...
Cached Medicine News:Health News:New Lung Cancer Guidelines Oppose General CT Screening 2Health News:New Lung Cancer Guidelines Oppose General CT Screening 3Health News:New Lung Cancer Guidelines Oppose General CT Screening 4Health News:AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System 2Health News:AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System 3Health News:AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System 4Health News:Common misdiagnosis: most women believe they have a yeast infection when they don't 2Health News:Sangamo BioSciences to Present at the ThinkEquity Partners Growth Conference 2Health News:Natural aorta grafts have few side effects for infection-prone patients 2Health News:Vitamin D Supplements May Lengthen Life 2
... developed a range of Milli-Q ultrapure ... water quality requirements. Each of the ... to specifically target contaminants detrimental to ... biology and ICP-MS. The systems incorporate ...
... Millipore has developed a range ... to match specific water quality requirements. ... systems is designed to specifically target ... as HPLC, molecular biology and ICP-MS. ...
... Bridge assembly allows internal or ... cooling coil allows rapid cool-down ... within approximately 10 C of ... is only 5.7 inches wideideal ...
Inquire...
Medicine Products: